Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations - Pohl, MA; Blumenthal, S; Cordonnier, DJ (J Am Soc Nephrol, 2005)